NovoCure Ltd
corporate_fare Company Profile
NovoCure Ltd (NASDAQ:NVCR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 26 items for NVCR at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- NovoCure Secures FDA Approval for Optune Pax in Pancreatic Cancer Amidst Mixed FY25 Financials and Clinical Setbacks
- NovoCure Reports Q4/FY25 Results, Guides Towards 2026 Profitability Amidst CMO Resignation
- CMS Reinstates NovoCure's Billing Privileges Retroactively, Reversing Prior Revocation
- NovoCure Receives FDA Approval for Optune Pax in Locally Advanced Pancreatic Cancer
- NovoCure's US Subsidiary Loses CMS Billing Privileges, Faces $13M Monthly Revenue Hit
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$655.35M
Net Income
-$136.23M
Diluted EPS
-$1.22
Op. Cash Flow
-$49.03M
Free Cash Flow
-$75.68M
Gross Profit
$488.47M
Operating Income
-$153.8M
Cash & Equivalents
$93.55M
Total Debt
$195.05M
Debt / Equity
0.57×
Net Margin
-20.8%
Shares Outstanding
112.49M sh
Source: 10-K · filed 2026-02-26 · accession 0001645113-26-000017
show_chartPrice Chart
Loading chart...
feed NVCR - Filings & News (Page 2)
NVCR
Feb 26, 2026, 7:01 AM EST
Price at Filing:
$14.48
Real-time Price:
$10.71
Change:
-$3.77 (-26%)
Market Cap:
$1.252B
NVCR
Feb 26, 2026, 7:01 AM EST
Price at Filing:
$14.48
Real-time Price:
$10.71
Change:
-$3.77 (-26%)
Market Cap:
$1.252B
NVCR
Feb 24, 2026, 5:00 PM EST
Price at Filing:
$12.71
Real-time Price:
$10.71
Change:
-$2.00 (-16%)
Market Cap:
$1.252B
NVCR
Feb 11, 2026, 5:24 PM EST
Price at Filing:
$10.50
Real-time Price:
$10.71
Change:
+$0.210 (+2%)
Market Cap:
$1.252B
NVCR
Feb 05, 2026, 8:00 AM EST
Price at Filing:
$11.51
Real-time Price:
$10.71
Change:
-$0.800 (-7%)
Market Cap:
$1.252B
NVCR
Jan 12, 2026, 7:00 AM EST
Price at Filing:
$14.35
Real-time Price:
$10.71
Change:
-$3.64 (-25%)
Market Cap:
$1.252B